[Steroid (glucocorticoid)-induced cataract].
Nishigori H.
Yakugaku Zasshi. 2006 Oct;126(10):869-84. doi: 10.1248/yakushi.126.869.
Topical corticosteroids for dry eye.
Liu SH, Saldanha IJ, Abraham AG, Rittiphairoj T, Hauswirth S, Gregory D, Ifantides C, Li T.
Cochrane Database Syst Rev. 2022 Oct 21;10(10):CD015070. doi: 10.1002/14651858.CD015070.pub2.
The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Black RJ, Hill CL, Lester S, Dixon WG.
PLoS One. 2016 Nov 15;11(11):e0166468. doi: 10.1371/journal.pone.0166468. eCollection 2016.
Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients.
Rice ML, Wong B, Horn PS, Yang MB.
J AAPOS. 2018 Jun;22(3):192-196. doi: 10.1016/j.jaapos.2018.01.017. Epub 2018 May 4.
Comparing glaucoma risk in children receiving low-dose and high-dose glucocorticoid treatment after cataract surgery.
Schmidt DC, Martinussen T, Solebo AL, Larsen DA, Bach-Holm D, Kessel L.
Acta Ophthalmol. 2025 Feb;103(1):43-49. doi: 10.1111/aos.16746. Epub 2024 Aug 12.
Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients.
Brignol TN, Fort PE, Ventura DF, Tadayoni R, Rendon A.
J AAPOS. 2018 Dec;22(6):483-484. doi: 10.1016/j.jaapos.2018.07.347. Epub 2018 Sep 26.
Prescription glucocorticoid medication and iridocyclitis are associated with an increased risk of senile cataract occurrence: a Mendelian randomization study.
Wen R, Xi YJ, Zhang R, Hou SJ, Shi JY, Chen JY, Zhang HY, Qiao J, Feng YQ, Zhang SX.
Aging (Albany NY). 2024 Jun 26;16(12):10563-10578. doi: 10.18632/aging.205963. Epub 2024 Jun 26.
Corticosteroids in Lupus.
Kasturi S, Sammaritano LR.
Rheum Dis Clin North Am. 2016 Feb;42(1):47-62, viii. doi: 10.1016/j.rdc.2015.08.007.
Reply.
Rice ML, Yang MB, Wong B.
J AAPOS. 2018 Dec;22(6):484-485. doi: 10.1016/j.jaapos.2018.10.004. Epub 2018 Oct 28.
Glucocorticoid-induced cataract of developing chick embryo as a screening model for anticataract agents.
Lee JW, Iwatsuru M, Nishigori H.
J Ocul Pharmacol Ther. 1995 Winter;11(4):533-41. doi: 10.1089/jop.1995.11.533.
